• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Parkway Life Real Estate Investment Trust (SGX:C2PU) Could Be 20% Undervalued As Half Year Earnings Land

    Simply Wall St·08/13/2026 17:22:20
    Listen to the news

    Parkway Life Real Estate Investment Trust (SGX:C2PU) has drawn investor focus after releasing half year 2026 earnings, along with a detailed 8.77 cent per unit distribution breakdown and key entitlement dates.

    See our latest analysis for Parkway Life Real Estate Investment Trust.

    At a share price of SGD4.13, Parkway Life Real Estate Investment Trust has seen modest positive share price momentum over the past quarter, while its 1 year total shareholder return of 4.57% and 3 year total shareholder return of 20.88% reflect steadier longer term gains.

    If the recent earnings and distribution update has you reviewing income ideas, it can also be useful to widen your radar with the 102 top founder-led companies

    With Parkway Life Real Estate Investment Trust units edging higher after the latest earnings and 8.77 cent distribution update, the real tension now is whether most of the upside is already in the price or still ahead as valuation comes into focus.

    Preferred P/E of 16.3x: Is it justified?

    On the current numbers, Parkway Life Real Estate Investment Trust trades on a P/E of 16.3x, which screens as relatively low against several benchmarks and sits alongside the recent SGD4.13 last close.

    The P/E ratio compares the current share price with earnings per unit and is a common way investors assess what they are paying for each dollar of profit. For a healthcare REIT such as Parkway Life Real Estate Investment Trust, this multiple often reflects expectations around recurring rental income, asset quality and the outlook for distributions.

    Simply Wall St data flags that the 16.3x P/E is below the peer average of 38.1x and also below the global Health Care REITs industry average of 17x. That points to the market assigning a lower price tag to each dollar of earnings than many similar companies, even though the stock is described as expensive versus an estimated fair P/E of 12.7x that our fair ratio work suggests the market could move towards over time.

    Explore the SWS fair ratio for Parkway Life Real Estate Investment Trust

    Result: Price-to-earnings of 16.3x (UNDERVALUED)

    However, Parkway Life Real Estate Investment Trust still faces risks such as slower net income growth and potential pressure on healthcare property demand, which could challenge the current P/E narrative.

    Find out about the key risks to this Parkway Life Real Estate Investment Trust narrative.

    Another view on Parkway Life Real Estate Investment Trust valuation

    While the 16.3x P/E makes Parkway Life Real Estate Investment Trust look relatively cheap against peers, the SWS DCF model presents a different perspective on value. At SGD4.13, the units trade about 20.4% below an estimated fair value of SGD5.19. Which signal carries more weight for you right now?

    Look into how the SWS DCF model arrives at its fair value.

    C2PU Discounted Cash Flow as at Aug 2026
    C2PU Discounted Cash Flow as at Aug 2026

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Parkway Life Real Estate Investment Trust for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 253 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

    Next Steps

    If this mix of signals on Parkway Life Real Estate Investment Trust feels balanced rather than one sided, it is worth checking the data now and forming your own view, then weighing up the 3 key rewards and 3 important warning signs

    Looking for more investment ideas beyond Parkway Life Real Estate Investment Trust?

    If Parkway Life Real Estate Investment Trust has sharpened your focus on valuation and income, now is a good moment to scan the wider market using powerful screeners.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.